Madison Square Garden Sports Corp. enters its August 13 earnings report with options sentiment at its most call-heavy in months, even as shorts sit at a moderate 6.4% of the float and the broader analyst community keeps lifting its targets.
The standout this week is in options positioning, and it tells an unusually bullish story. The put/call ratio has dropped to 0.62, nearly two standard deviations below its 20-day average of 0.71 — meaning options traders are buying calls at a rate that looks aggressive relative to recent habit. That reading is close to the 52-week low of 0.49, and the shift has been consistent: the PCR ran above 0.70 throughout most of July before falling sharply in early August as the earnings date approached. The pattern suggests the options market is leaning into a positive result rather than hedging against a miss.
Short interest tells a more neutral story. At 6.4% of the float, bears hold a meaningful but shrinking position — down roughly 6% over the past month and off marginally this week. The borrow market is wide open, with availability running at 1,100%, meaning there are more than ten times as many shares available to borrow as are currently lent out. Borrowing cost has crept up 12% week-on-week to 0.52%, but that remains firmly in "low" territory by any standard. Nothing in the lending market suggests squeeze pressure or unusual demand for new short positions.
The Street has been consistently constructive, and the direction of recent analyst activity reinforces that lean. JP Morgan raised its target from $400 to $450 in late July, maintaining Overweight. Guggenheim went further, lifting to $522 from $470 at roughly the same time, keeping its Buy. Both moves followed the prior quarter's beat — MSGS rose 1.8% the day after its May print and a further 6.6% over the following week. The mean consensus target of $441 implies around 12% upside from current levels at $393, though bulls at Guggenheim see potential well above that. The bear case centres on team performance risk, NBA luxury-tax exposure, and the open question of timing on any Knicks/Rangers spin-off catalyst; Citi sits at Neutral with a $360 target, the most sceptical voice in the group.
Institutional ownership adds an interesting layer to the setup. BlackRock added nearly 87,000 shares in its most recent filing, pushing its stake to 8.7% of shares outstanding. Starlite Capital appears as a new entrant with a 5% position, and T. Rowe Price added around 27,000 shares in June. The Dolan family, through the trust, remains the anchor at 19.2% — a concentration of voting power the bear case regularly flags as a governance concern. Insider activity in the data is too dated (last transaction February 2026) to carry meaningful weight this week.
The next print arrives Thursday morning, and the question for investors is less about whether the franchise assets are valuable and more about what management says on spin-off timing, NBA expansion economics, and the trajectory of team-related costs heading into next season.
See the live data behind this article on ORTEX.
Open MSGS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
